LZ901 Vaccine Shows Efficacy, Immunogenicity, and Safety in Adults Aged 40+
Herpes zoster, commonly known as shingles, is being targeted by a new vaccine candidate in a large phase 3 clinical ...
Tag: postherpetic neuralgia prevention
New gE-Fc Subunit Vaccine Shows Safe, Effective Protection
In a significant advancement for infectious disease prevention, researchers have unveiled a novel vaccine candidate targeting herpes zoster, commonly known ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!